JCD Platelet-Rich Plasma and Hyaluronic Acid - An Efficient RAD
JCD Platelet-Rich Plasma and Hyaluronic Acid - An Efficient RAD
Summary Background Cosmetic applications of platelet-rich plasma (PRP) are new, and reports
are scarce and dispersed in the literature. There are a variety of commercially
available kits and injection techniques, and the number and intervals of injections
vary. New investigations should focus on developing a standardized procedure for
PRP preparation and application methods to augment its efficacy and potency.
Objectives In this report, we aim to provide data and commentary to assist and add to
current guidelines.
Methods A series of 94 female patients with varying degrees of facial aging signs were
treated with PRP and hyaluronic acid (HA). Mean age was 53.0 5.6. The mean
injection number was 3.6 2.0. Platelet-poor and platelet- rich plasma parts were
mixed with 0.5 cc %3.5 hyaluronic acid and 0.5 cc procaine and injected with a
30G, 13-mm needle into deep dermis and hypodermis. Patients were asked to rate
their personal satisfaction with their skin texture, pigmentation, and sagging. In
addition, the overall results were rated by three independent physicians and the
patients themselves. The outcomes were peer-reviewed, and correlations between the
degree of the aesthetic scores and the number of injections were explored.
Results There was a statistically significant difference in general appearance, skin
firmness-sagging and skin texture according to the patients’ before and after
applications of PRP. A statistically significant correlation was found between the
number of injections and overall satisfaction.
Conclusions Compared to the baseline, the PRP and HA injections provided clinically
visible and statistically significant improvement on facial skin. The improvements
were more remarkable as the injection numbers increased.
Keywords: platelet-rich plasma (PRP) injection number, hyaluronic acid, facial
rejuvation, injection, biostimulation, collagen
three factors: cells, chemical substances and scaffolds. The mean number of injections was 3.6 2.0
Platelet-rich plasma is a rich source of growth factors (median: 3.0, range 1–8).
and provides a scaffold to support true tissue regener- The same preparation technique was used, and all
ation. Therefore, PRP is included within the field of applications were performed by the same physician
regenerative medicine. Precursor cell migration, prolif- (BGU).
eration and differentiation are intended biological Written informed consent was obtained before the
effects theoretically related to the PRP clinical procedure. Anticoagulants were stopped 1 week earlier
response.3–6 to prevent the formation of excessive bruising. Treat-
Loss of viscoelasticity is one of the primary signs of ment was avoided in pregnant and breastfeeding moth-
skin aging, followed by the appearance of visible wrin- ers. Autoimmune diseases such as Hashimato’s
kles. A key molecule involved in maintaining skin thyroiditis and metabolic disorders such as diabetes
hydration is hyaluronic acid (HA).7 The HA concentra- mellitus were not contraindications.
tion in the skin is determined by the complex balance About 12.5 cc of patients’ own blood was collected
between the skin’s synthesis, deposition, association in a syringe with 1.5 cc of 10% Na citrate. No activa-
with7 cellular structures and degradation. tor was used. Then, whole blood was instilled to a PRP
Recent basic research supports the idea that HA and kit (Dr B PRPTM) and centrifuged at 1800 rpm for 20–
PRP treatments can be advantageously associated 50 min until all red blood cells separate from plasma
without altering the original relevant characteristics of and the buffy coat became clearly visible. If the inten-
both products. When both products are injected, their tion was to treat the whole facial and neck region, the
effects might be additive to enhance the anabolic func- plasma and the buffy coat (platelet-rich and platelet-poor
tion of dermal fibroblasts.8,9 plasma) were collected in 5 cc syringes and infiltrated
However, the clinical outcomes of PRP and HA along the wrinkles with a 30G and 0.3 9 13 mm nee-
co-injection on aging facial skin have not been eluci- dle. Platelet-rich plasma portion was separately collected
dated for human subjects. if a specific local region was intended to be treated
The treatment protocol, including the number and (such as dark under-eye circles). In all cases, PRP was
intervals of injection and application methods, varies. mixed with 0.5 cc %3.5 hyaluronic acid gel and
In most clinical reports, up to three injections were 0.5 cc procaine. To reduce pain, local anesthetic cream
performed for cosmetic purposes.10 The number of and ice were applied before the procedure. Then, small
patients in these reports was limited, and the available aliquots of plasma were infiltrated 5–6 mm deep into
guidelines are arbitrary. Growth factors are not muta- the dermis and hypodermis through hundreds of
genic and whether additional injections have the micro-needle holes with a 30 G, 13-mm needle
potential to provide superior cosmetic results is not (Fig. 1). At the end of the treatment, ice and antibiotic
known yet. cream were applied locally and patients were asked to
In this article, the objective was to propose new avoid any contact with their face and neck for 3–4 h.
guidelines for optimal doses, treatment intervals, num- Vitamin C (1000 mg/day) and sun protection were
ber of injections and application method for PRP. We recommended.
also aim to analyse the effect of PRP and HA therapy The treatment was staged as “intense” and “mainte-
for face rejuvenation. nance” periods. In the intense treatment period, con-
To the best of our knowledge, this article presents secutive three treatments were performed 3–4 weeks
the largest series of patients who underwent PRP appli- apart. Patients were advised to receive at least three
cation with the intention of rejuvenating the face. treatments for more visible results. In the maintenance
Using the same kit and preparation methods, all appli- period, patients received up to five sessions at eight- to
cations were performed by the same physician (BGU). ten-week intervals.
The study data have the potential to clarify conflicting All of the treated patients were reached by phone
data in the literature and lead to updates in the appli- and asked to rate their satisfaction on a scale ranging
cation methods. from 0 to 3 (0 = no improvement, 1 = slight improve-
ment, 2 = moderate improvement, and 3 = good
improvement) for overall improvement and individual
Methods
satisfaction with skin texture, skin sagging/firmness
Between December 2012 and November 2015, 94 and skin pigmentation. In addition using the same rat-
female patients were treated for facial rejuvenation ing scale, three independent physicians rated the over-
using PRP and HA. The mean age was 53.0 5.6. all aesthetic improvement by assessing before and after
Table 1 The number of injections, number of patients, mean WSRS, and improvement scores given by patients and physicians
Figure 3 (FRONTAL VIEW) Facial rejuvenation was more obvious with additional (more than 3) PRP +HA injections. Appearance of a
53-year-old patient before the onset of treatment (a) Appearance of the same patient after three PRP+HA injections (b). The facial skin
texture seems healthier. The pigmentation and fine wrinkles were improved. Appearance of the same patient after eight PRP+HA injec-
tions (19 months after the onset of the treatment) (c). Sagging facial skin at the periorbital and cheek region was further improved. The
nasolabial fold was better although no tissue filler was used. Dermabrasion was performed on to the upper lip because the response to
the treatment was poor.
Figure 4 (LATERAL VIEW)The same patient after eight PRP+HA injections. Tightening of the sagging cheek and neck skin is more
prominent.
The platelet concentration was 5–6 times higher hemorrhages and activate wound healing mechanisms
(1389 000/lL) compared to the baseline levels without damaging the epidermis. Post-traumatic regen-
(244 000/lL) (Fig. 10) However, the centrifugation eration of the skin forms a thicker epidermis with the
times varied between 20 and 50 min, and how these formation of new subepidermal collagen and elastin
periods affect platelet cell integrity and concentrations network. Needling is known to have a distinct poten-
require further investigation. tial to induce collagen and elastin formation apart
We injected platelet-poor plasma part along with from growth factor instillation.23,24
PRP with intention to inject more cells, further hydrate After the injection, we advised the patient to take
the skin, and to induce percutaneous collagen induc- 1000 mg/day vitamin C. This vitamin is essential for
tion by needling. Fine pricks create intradermal the formation of stable collagen I and III fibrils and
Figure 5 Significant increase in skin moisture, improved hydration and shiny skin which became evident within the first few months
after the PRP+HA application.
Figure 7 Due to the thickening and hydration of the dermis, dry and parchment-like sagging skin gradually recovered, and telengiecta-
sis became less visible.
thus has a supportive function in building up a duration of the botox. To the best of our knowledge,
healthy collagen–elastin matrix.25 no other method produces this effect. However, we
One interesting note is that this patient series, PRP cannot suggest an explanation for this with existing
and HA injection after botox application shortened the data.
Figure 8 A change in the quality and texture of the skin which became evident after five sessions of PRP +HA injections.
Figure 9 Facial fullness was restored in this patient, and improvement in sagging was significant after seven sessions of PRP+HA
injections.
Figure 10 Platelet concentration was 5–6 times higher (1389 000/lL) compared to the baseline levels (244 000/lL) in the platelet
separation kit used in this series of patients.
The significant outcomes from this study showed 12 Grove GL. Physiologic changes in older skin. Clin Geriatr
that biostimulation for facial rejuvenation and repair is Med 1989; 5: 115.
possible through the injection of PRP and HA. Growth 13 Waller JM, Maibach HI. Age and skin structure and func-
factor and HA instillation into the skin and SMAS tis- tion, a quantitative approach (I): blood flow, pH, thick-
ness, and ultrasound echogenicity. Skin Res Technol 2005;
sues and the additive effect of needling trauma for per-
11: 221–35.
cutaneous collagen induction allowed us to obtain
14 Harvell JD, Maibach HI. Percutaneous absorption and
satisfactory results. inflammation in aged skin: a review. J Am Acad Dermatol
1994; 31: 1015–21.
15 Cho JW, Kim SA, Lee KS. Platelet-rich plasma induces
References
increased expression of G1 cell cycle regulators, type I
1 Kirkwood TB. Understanding the odd science of aging. collagen, and matrix metalloproteinase-1 in human skin
Cell 2005; 120: 437–47. fibroblasts. Int J Mol Med 2012; 29: 32–6.
2 Rando TA. Stem cells, ageing and the quest for immortal- 16 Kim DH, Je YJ, Kim CD et al. Can platelet-rich plasma be
ity. Nature 2006; 441: 1080–6. used for skin rejuvenation? Evaluation of effects of plate-
3 Torricelli P, Fini M, Filardo G et al. Regenerative medicine let-rich plasma on human dermal fibroblast. Ann Dermatol
for the treatment of musculoskeletal overuse injuries in 2011; 23: 424–3.
competition horses. Int Orthop 2011; 35: 1569–76. 17 Leach JB, Bivens KA, Collins CN et al. Development of
4 Okabe K, Yamada Y, Ito K et al. Injectable soft-tissue aug- photocrosslinkable hyaluronic acid-polyethylene glycol-
mentation by tissue engineering and regenerative medi- peptide composite hydrogels for soft tissue engineering.
cine with human mesenchymal stromal cells, platelet-rich J Biomed Mater Res A 2004; 70: 74–82.
plasma and hyaluronic acid scaffolds. Cytotherapy 2009; 18 Dechert TA, Ducale AE, Ward SI et al. Hyaluronan in
11: 307–16. human acute and chronic dermal wounds. Wound Repair
5 Wu CC, Chen WH, Zao B et al. Regenerative potentials of Regen 2006; 14: 252–8.
platelet-rich plasma enhanced by collagen in retrieving 19 Schmitz JP, Hollinger JO. The biology of platelet-rich
pro-inflammatory cytokine-inhibited chondrogenesis. Bio- plasma. J Oral Maxillofac Surg 2001; 59: 1119–21.
materials 2011; 32: 5847–54. 20 Har-Shai Y, Bodner SR, Egozy-Golan D et al. Viscoelastic
6 Sanchez-Gonz alez DJ, Mendez-Bolaina E, Trejo-Bahena NI. properties of the superficial musculoaponeurotic system
Platelet-rich plasma peptides: key for regeneration. Int J (SMAS): a microscopic and mechanical study. Aesthetic
Pept 2012; 2012: 532519. Plast Surg 1997; 21: 219–24.
7 Narurkar VA, Fabi SG, Bucay VW et al. Rejuvenating 21 Andia I, S anchez M, Maffulli N. Platelet rich plasma
hydrator: restoring epidermal hyaluronic acid homeosta- therapies for sports muscle injuries: any evidence behind
sis with instant benefits. J Drugs Dermatol 2016; 15: s24– clinical practice? Expert Opin Biol Ther 2011; 11:
37. 509–18.
8 Anitua E, Sanchez M, De la Fuente M et al. Plasma rich 22 Li ZJ, Choi HI, Choi DK et al. Autologous platelet-rich
in growth factors (PRGF-Endoret) stimulates tendon and plasma: a potential therapeutic tool for promoting hair
synovial fibroblasts migration and improves the biological growth. Dermatol Surg 2012; 38: 1040–6.
properties of hyaluronic acid. Knee Surg Sports Traumatol 23 Zeitter S, Sikora Z, Jahn S et al. Microneedling: matching
Arthrosc 2012; 20: 1657–65. the results of medical needling and repetitive treatments
9 Anitua E, S anchez M, Nurden AT et al. Platelet-released to maximize potential for skin regeneration. Burns 2014;
growth factors enhance the secretion of hyaluronic acid 40: 966–73.
and induce hepatocyte growth factor production by syn- 24 Aust MC, Reimers K, Kaplan HM et al. Percutaneous col-
ovial fibroblasts from arthritic patients. Rheumatology lagen induction-regeneration in place of cicatrisation? J
(Oxford) 2007; 46: 1769–72. Plast Reconstr Aesthet Surg. 2011; 64: 97–107.
10 Leo MS, Kumar AS, Kirit R et al. Systematic review of the 25 Nusgens BV, Humpert P, Rougier A et al. Topically
use of platelet-rich plasma in aesthetic dermatology. J applied vitamin C enhances the mRNA level of collagens
Cosmet Dermatol 2015; 14: 315–23. I and III, their processing enzymes and tissue inhibitor of
11 Bioulac B, Heppt W, Heppt M. Transfer of autologous fat matrix metalloproteinase 1 in the human dermis. J Invest
and plasma: the future of anti-aging medicine? HNO Dermatol 2001; 116: 853–9.
2015; 63: 497–503.